Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Xie

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Life Medicine|January 28, 2025
Spatiotemporal Omics-Refining the landscape of precision medicineJiajun Zhang, Jianhua Yin, Yang Heng, et al.
Cell|January 19, 2024
Bispecific dendritic-T cell engager potentiates anti-tumor immunityYuval Shapir Itai, Oren Barboy, Ran Salomon, et al.
Cancer Cell|January 23, 2026
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cellsGal Yagel, Dana Rimini, Michelle von Locquenghien, et al.
Nature Communications|June 16, 2026
EasySCP unveils extensive liver zonation at single-cell proteomics resolutionBingbing Hao, Jinghui Wei, Jiaen Xu, et al.
Cell|November 20, 2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapyMichelle von Locquenghien, Pascale Zwicky, Ken Xie, et al.
Cancer Cell|April 11, 2025
ZEB2 is a master switch controlling the tumor-associated macrophage programFadi Sheban, Truong San Phan, Ken Xie, et al.
Cell|December 22, 2023
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastomaDaniel Kirschenbaum, Ken Xie, Florian Ingelfinger, et al.
Nature Medicine|April 27, 2023
The transcriptional and regulatory identity of erythropoietin producing cellsBjørt K Kragesteen, Amir Giladi, Eyal David, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Life Medicine|January 28, 2025
Spatiotemporal Omics-Refining the landscape of precision medicineJiajun Zhang, Jianhua Yin, Yang Heng, et al.
Cell|January 19, 2024
Bispecific dendritic-T cell engager potentiates anti-tumor immunityYuval Shapir Itai, Oren Barboy, Ran Salomon, et al.
Cancer Cell|January 23, 2026
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cellsGal Yagel, Dana Rimini, Michelle von Locquenghien, et al.
Nature Communications|June 16, 2026
EasySCP unveils extensive liver zonation at single-cell proteomics resolutionBingbing Hao, Jinghui Wei, Jiaen Xu, et al.
Cell|November 20, 2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapyMichelle von Locquenghien, Pascale Zwicky, Ken Xie, et al.
Cancer Cell|April 11, 2025
ZEB2 is a master switch controlling the tumor-associated macrophage programFadi Sheban, Truong San Phan, Ken Xie, et al.
Cell|December 22, 2023
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastomaDaniel Kirschenbaum, Ken Xie, Florian Ingelfinger, et al.
Nature Medicine|April 27, 2023
The transcriptional and regulatory identity of erythropoietin producing cellsBjørt K Kragesteen, Amir Giladi, Eyal David, et al.
Pageof 1